Reuters reported exclusively that Canada’s drug pricing agency is contemplating significant changes to how it will apply new regulations aimed at lowering costs, as drugmakers unhappy with the policy delay introducing new medicines in the country and blame it for job cuts. Canada in August passed the new regulations for medicines under patent protection despite heavy lobbying from drug companies that stand to lose billions in revenue.
Reuters reveals Canadian regulator considering changes to new drug pricing plan
20 February 2020, 12:00 am. 1 minute
Article Tags
More of Reuters Best
Reuters exclusively reports Indian sugar mills to close early as rain hits cane supply; sugar futures jump; shares fall
January 29, 2023
Reuters reveals that India may peg gross borrowing under 16 trillion rupees in 2023/24
January 27, 2023